IRCT2017012031423N1已完成2 期
Evaluation of influence of Curcumin on non-invasive liver marker`s in patients with nonalcoholic fatty liver disease
Vice Chancellor for research of Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 60 years（—）
- 性别
- All
入选标准
- •1. having ALT and AST upper than highest normal level
- •2. have at least one of the following:
- •A) Diabetes
- •B) Hyperlipidemia
- •3. The age of 15 to 60
- •Exclusion criteria:
- •1. Alcohol consumption
- •2. Get a positive serology of viral hepatitis
- •3. ANA or AMA positive test, Alpha1 Antitrypsin, Low serum levels of Seroloplasin or high levels of antibodies of ASMA or LKM.
- •4. High ferritin 450 or Iron/TIBC> 45%
- •5. The patient before the intervention or during the intervention, affected with acute or chronic disease that causes in LFT disorders.
- •6.The patient before the intervention or during the intervention is consuming medicine that potentially capable of Disrupting the LFT.
- •7. Pregnancy
- •8. Patients Younger than 15 or older than 60.
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Evaluation of the effect of curcumin in the prevention of vancomycin-induced nephrotoxicity in patients hospitalized in the intensive care unit of Kosar Hospital, Semnan: a randomized, double-blinded, placebo-controlled clinical trialIRCT20240501061620N1Semnan University of Medical Sciences70
已完成
3 期
Evaluation of the effectiveness of curcumin in the prevention of contrast induced nephropathy in following coronary AngiographyContrast induced nephropathy in following coronary angiography.Nephrotic syndromeIRCT20190911044744N4Yazd University of Medical Sciences60
尚未招募
3 期
The effect of curcumin on arterial stiffnessIRCT20180619040151N2Mashhad University of Medical Sciences80
Unknown
2 期
An invivo study to evaluate the role of curcumin in oral pre-malignant lesions and gingivo-buccal cancersCTRI/2008/091/000193DBT90
招募中
1 期
Evaluation of the effectiveness of Curcumin in the improving patients with autoimmune hepatitisAutoimmune hepatitisIRCT20221112056476N1Zahedan University of Medical Sciences68